Sale!

HLA – DR5 DRB1*1112 Test

1,010 د.إ

-10%

The HLA – DR5 DRB1*1112 test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify specific alleles of the HLA-DRB1 gene, particularly the DRB1*1112 allele. This test is crucial for understanding an individual’s Human Leukocyte Antigen (HLA) profile, which plays a significant role in the immune system’s ability to distinguish between self and non-self molecules. Identifying the presence of the HLA-DR5 DRB1*1112 allele can be vital for various medical purposes, including but not limited to, assessing organ transplant compatibility, understanding susceptibility to certain autoimmune diseases, and tailoring personalized medicine approaches.

The test is conducted through a blood sample or a cheek swab, which is then analyzed using sophisticated genetic sequencing technologies to detect the specific allele. DNA Labs UAE, known for its state-of-the-art facilities and expert staff, offers this test at a cost of 1010 AED. The lab ensures accuracy and confidentiality in handling test results, making it a reliable choice for patients and healthcare providers seeking comprehensive HLA profiling.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HLA – DR5 DRB1*1112 Test

Components: 4 mL (3 mL min.) whole blood in 1 Lavender Top (EDTA) tube OR 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube. Ship refrigerated. DO NOT FREEZE.

Price: 1010.0 AED

Report Delivery: 10-12 days

Method: Reverse SSOP – Luminex

Test Type: Disease Association

Doctor: Physician

Test Department: Pre Test Information

No special preparation required.

Test Details

The HLA-DR5 (DRB1*11/12) test is a genetic test that identifies the presence of the HLA-DR5 gene variant in an individual’s DNA. HLA genes encode for proteins called human leukocyte antigens (HLAs), which play a crucial role in the immune system’s ability to recognize and respond to foreign substances, such as bacteria and viruses.

The HLA-DR5 variant is associated with an increased risk of developing certain autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. This test is often used to assess an individual’s genetic susceptibility to these diseases and to aid in their diagnosis.

The test is typically performed using a blood sample or a cheek swab, and the DNA is analyzed to determine the presence or absence of the HLA-DR5 variant. The results can help healthcare professionals in assessing a person’s risk of developing autoimmune diseases and may guide treatment decisions or preventive measures.

It is important to note that having the HLA-DR5 variant does not necessarily mean a person will develop an autoimmune disease, as other genetic and environmental factors also contribute to disease development. Additionally, the absence of the HLA-DR5 variant does not rule out the possibility of developing autoimmune diseases.

The HLA-DR5 (DRB1*11/12) test is typically ordered by a healthcare provider, such as a rheumatologist or immunologist, and the results are interpreted in conjunction with other clinical and laboratory findings to make an accurate diagnosis and develop an appropriate treatment plan.

Test Name HLA – DR5 DRB1*1112 Test
Components
Price 1010.0 AED
Sample Condition 4 mL (3 mL min.) whole blood in 1 Lavender Top (EDTA) tube OR6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube. Ship refrigerated. DO NOT FREEZE.
Report Delivery 10-12 days
Method Reverse SSOP – Luminex
Test type Disease Association
Doctor Physician
Test Department:
Pre Test Information No special preparation required
Test Details

The HLA-DR5 (DRB1*11/12) test is a genetic test that identifies the presence of the HLA-DR5 gene variant in an individual’s DNA. HLA genes encode for proteins called human leukocyte antigens (HLAs), which play a crucial role in the immune system’s ability to recognize and respond to foreign substances, such as bacteria and viruses.

The HLA-DR5 variant is associated with an increased risk of developing certain autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. This test is often used to assess an individual’s genetic susceptibility to these diseases and to aid in their diagnosis.

The test is typically performed using a blood sample or a cheek swab, and the DNA is analyzed to determine the presence or absence of the HLA-DR5 variant. The results can help healthcare professionals in assessing a person’s risk of developing autoimmune diseases and may guide treatment decisions or preventive measures.

It is important to note that having the HLA-DR5 variant does not necessarily mean a person will develop an autoimmune disease, as other genetic and environmental factors also contribute to disease development. Additionally, the absence of the HLA-DR5 variant does not rule out the possibility of developing autoimmune diseases.

The HLA-DR5 (DRB1*11/12) test is typically ordered by a healthcare provider, such as a rheumatologist or immunologist, and the results are interpreted in conjunction with other clinical and laboratory findings to make an accurate diagnosis and develop an appropriate treatment plan.